Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may repeatedly activate and delay skin repair

In a of , and , fluctuating may repeatedly activate , prolonging skin growth. Reject this if variability below the leaves repeat activations unchanged, or changing them does not affect repair completion.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

The biological function description is being prepared

Direction

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Lens
Stochastic inflammatory reexcitation
Goal
Самоограничение регенерации при повторных циклах восстановления
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
7 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling pathway

    activation

    Activation of the nuclear factor within an intracellular inflammatory cascade

    Where this hypothesis actsLocal after a sleep shift, during repeated treatments timed to epidermal rhythms

    Hypotheses on this target 1
    NF-κB activationInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Desensitisation
    • Function preservation
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Inhibition

    Reduce the probability of repeated activation between treatments

    With whatChange of environment or regimen

    HowChoose treatment timing using individually estimated probabilities of inflammatory reactivation rather than average intertissue phase delays alone

    Possible result

    Possible reduction in persistent , and incomplete repair

    From the recordдля устойчивости SPV_6 требуется ограничить вероятность повторного запуска воспаления.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionNF-κB activation. Hypotheses on this target 1NF-κB activation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin repair may finish less completely when treatments arrive before the effects of earlier treatments have settled. The unexpected move is that an inflammatory response could end normally each time, yet repeated fresh starts could keep repair unfinished. This is a proposal generated by the pipeline, not a measured result: treatment timing would need to account for the chance of another inflammatory restart, beyond average differences between .

The proposed mechanism, link by link
  1. A shift in sleep timing is proposed to place treatment timed to the outer skin layer within a period when local respond more readily.
  2. Weak inflammatory signals fluctuate, occasionally pushing internal cell activity above the level that triggers .
  3. Each activation ends and the trigger resets; the proposed change is from an ended response that stays quiet to an ended response followed by fresh brief activations.
  4. Fresh activations repeatedly renew and sustain growth in the deeper skin layer.
  5. Restarts between treatments are proposed to increase the accumulation of unfinished repair.
  6. Scheduling treatments by the estimated chance of a restart is predicted to improve completion of repair compared with scheduling by average tissue-clock delays alone.
A picture for it

A motion-sensitive light can switch off properly after every activation yet keep a room lit for much of the night if small movements repeatedly switch it back on. The problem lies in fresh triggers, even though the switch-off works.

Where the picture breaks: The picture explains separate restarts but does not establish that inflammatory activity has the proposed trigger-and-reset behavior, that sleep timing changes its sensitivity, or that repeated activation delays skin repair.

  1. Master questionstep 01 of 04

    The goal is a therapy that brings the functional condition of middle-aged people's skin closer to that of young people's skin.

    Rests on: The supplied goal explicitly names younger skin function as the intended outcome; it does not report that this outcome has been achieved.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The chosen focus is how , the rebuilding of damaged tissue, limits itself across repeated rounds of repair.

    Rests on: This narrows the broad goal of improving skin function to the control of repeated repair.

    Leap

    The goal does not supply evidence that limits on repeated explain the functional difference between middle-aged and young skin, or that changing those limits would close that difference.

  3. Gap questionstep 03 of 04

    After a shift in sleep timing, scheduling treatment by the daily clock of the , the skin's outer layer, might increase its timing mismatch with the , the supporting layer beneath it, and , which help regulate defense and . The question is whether accounting for delays between these prevents unfinished repair from accumulating.

    Rests on: Repeated repair supplies the concern about accumulation, but the preceding stage does not identify sleep timing or differences between as its cause.

    Leap

    The supplied material does not establish that treatment timed to the outer skin layer after a sleep shift worsens coordination between tissues, or that correcting their average timing differences prevents unfinished repair.

  4. Hypothesisstep 04 of 04

    Random fluctuations in inflammatory signals are proposed to trigger separate, repeated activations of , abbreviated , a regulator that controls the activity of genes involved in . Each response would end, but new responses would sustain and growth in the deeper skin layer. The proposed scheduling target is therefore the probability of another restart between treatments.S3

    Rests on: S3, published in Oxidative Medicine and Cellular Longevity in 2020, suggested possible greater readiness for reactivation in cultured human , cells of the outer skin layer, after ozone exposure. Its reported measurements could not distinguish inside the from outside it; it does not establish random restarts in after a sleep shift or their effect on skin repair. The hypothesis extends that possibility using a mathematical model in which fluctuating activity reaches a trigger level, resets and temporarily becomes unable to trigger again.

    Supported by literature

What is carried, and what is not. Of the six proposed mechanism links, one has a directly relevant partial precedent: the possibility of renewed activation described by S3, with the cell-type, exposure and measurement limits stated above. Other supplied sources provide background, but none establishes the complete sequence from shifted sleep through repeated inflammatory restarts to unfinished repair or improved treatment scheduling.S3

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The goal does not supply evidence that limits on repeated explain the functional difference between middle-aged and young skin, or that changing those limits would close that difference. Establish the missing link before relying on this step.
  • Gap question. The supplied material does not establish that treatment timed to the outer skin layer after a sleep shift worsens coordination between tissues, or that correcting their average timing differences prevents unfinished repair. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A culture could appear to produce random restarts because different cells have consistently different sensitivities, or because one prolonged response is counted as several separate responses. What closes it: Follow the same cells across repeated exposures, confirm a regime where the mean input is below the , and define a separate activation before counting events. Measure return toward the inactive state and the temporary interval during which another response cannot start. The specification explicitly requires separating stable differences between cells from randomness within each cell's repeated responses.
  • Changing could also change total inflammatory exposure, tissue-clock timing or the rival mechanism's growth restraint, making an effect look specific to random inflammatory restarts. What closes it: The comparison must match measured tissue-clock timing, total local cytokine exposure, meaning accumulated exposure to cell-to-cell signaling proteins, and the state of , small cell projections proposed by the rival to restrain renewed cell division. Match treatment count, total treatment exposure and observation time when comparing schedules. The specification requires these comparisons but does not provide a complete measurement protocol.
  • More activations alongside continued cell division could be read as proof that the activations prevent repair from finishing, even if both respond to another cause or cell division changes without repair completion changing. What closes it: Measure repair completion alongside activation counts and residual cell division, with completion criteria fixed before testing. A causal test must change the restarts and establish whether completion changes under the matched conditions; the supplied specification does not identify an intervention that isolates this effect or define the completion criteria.

What would make this wrong. The proposed mechanism would fail if, after confirming the below-threshold operating regime and separating stable cell differences from within-cell randomness, changing inflammatory-input variability did not change separate restarts, or if changing those restarts did not change repair completion. These are the hypothesis's stated failure conditions; merely failing to alter the intended input would not establish either one.

What it would change. If the hypothesis held, repeated skin treatments would need to account for the chance of inflammatory restarts between procedures, even when average tissue-clock delays were known. Work toward younger skin function would therefore need to test whether schedules based on that probability improve completion of repeated repair. A first result in a shared culture of skin and would still not establish the effect of an actual sleep shift, lasting benefits in intact middle-aged human skin, or restoration to young people's functional condition; the supplied input also leaves its named scheduling target undefined.

Sources read · 9

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1BackgroundAbstract only

Sleep deprivation and the skin. · Clinical and experimental dermatology · 2023

“The focus of our review article is to explore the bidirectional relationship between sleep and cutaneous disease investigating the disruption in circadian rhythmicity and skin homeostasis.”

Does not settle: Источник не устанавливает повторную активацию NF-κB, пороговые события, возбудимость местных иммунных клеток, задержку заживления или вероятность воспалительных запусков между процедурами.

S2Background

Taurine Prevents Impairments in Skin Barrier Function and Dermal Collagen Synthesis Triggered by Sleep Deprivation-Induced Estrogen Circadian Rhythm Disruption. · Cells · 2025

“This study reveals that chronic sleep deprivation disrupts estradiol circadian rhythms, resulting in compromised epidermal barrier function and diminished dermal collagen synthesis.”

Does not settle: It does not assess NF-κB activation, repeated inflammatory reactivation, local immune-cell excitability, event probabilities between procedures, or repair scheduling.

S3Partly answers it

Circadian Clock and OxInflammation: Functional Crosstalk in Cutaneous Homeostasis. · Oxidative medicine and cellular longevity · 2020

“This data further indicated the possibility that the cells are more prone to reactivate NF- κ B (nuclear translocation) in the eventuality of a further challenge. Indeed at this time, it is not possible to discriminate between NF- κ B nuclear and cytoplasmic levels.”

Does not settle: Источник изучал культуру человеческих кератиноцитов после воздействия озона. Остаются открытыми связь со сдвигом сна, повторные случайные активации NF-κB, воспаление и восстановление кожи, а также вероятность событий между процедурами и требования к расписанию SPV_6.

S5Background

Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. · Frontiers in immunology · 2022

“TIR-domain-containing adaptor-inducing interferon-β (dependent on TRIF) can be recruited and then activates TRAF6, and IκBs (especially IκBα) can degrade leading to the release of NF-κB (P50/65) and its translocation to the nucleus, which can promote the M1 polarization.”

Does not settle: This source does not establish sleep-shift effects, epidermal or skin repair outcomes, repeated or stochastic NF-κB reactivation, event probabilities between procedures, or any scheduling threshold for SPV_6.

S6Background

NF-κB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells. · Frontiers in immunology · 2023

“Moreover, recent findings highlighted the temporal dynamics of myeloid NF-κB activation and underlined the complexity of this inflammatory master regulator.”

Does not settle: This review excerpt does not establish effects of sleep shifts, epidermis-localized exposure, repeated NF-κB reactivation thresholds, probabilities between procedures, or delayed skin repair.

S7Background

Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling. · Frontiers in immunology · 2021

“LPS-induced polarization of M1 depends on activation of NF-κBp65, and treatment with IκB kinase-β inhibitors reduces M1-labeled mRNA expression ( ).”

Does not settle: Источник не устанавливает влияние сдвига сна, эпидермально привязанного воздействия, случайных или повторных активаций NF-κB, вероятности событий между процедурами либо задержки восстановления кожи. Описываются сигнальные пути макрофагов при периодонтите.

S8Background

O-GlcNAcylation dictates pyroptosis. · Frontiers in immunology · 2024

“NF-κB acts as a pivotal mediator in initiating the priming signal required for NLRP3 inflammasome activation, orchestrating the transcriptional upregulation of NLRP3 and pro-IL-1β in response to various pattern recognition receptors (PRRs) ligands and cytokines ( , ).”

Does not settle: Источник не устанавливает связь сдвига сна с эпидермальными иммунными клетками, повторной активацией NF-κB, вероятностным порогом таких событий, заживлением кожи или интервалами между процедурами.

S9Background

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026

“Key pathways include PI3K/Akt and MAPK, which promote fibroblast proliferation, collagen synthesis, and angiogenesis; TGF-β signaling, which orchestrates extracellular matrix remodeling; and NF-κB inhibition, which regulates inflammation resolution (Table ).”

Does not settle: This review does not establish effects of sleep shifts, epidermis-bound exposure, local immune-cell excitability, stochastic NF-κB reactivation, repeated activation probabilities between procedures, dermal growth, or an SPV_6 scheduling threshold.

S10BackgroundAbstract only

Circadian Rhythm-Regulated ADSC-Derived sEVs and a Triphasic Microneedle Delivery System to Enhance Tendon-to-Bone Healing. · Advanced materials (Deerfield Beach, Fla.) · 2024

“Herein, the circadian rhythm of adipose-derived stem cells is modulated to increase the yield and enhance the inflammatory regulatory capacity of sEVs.”

Does not settle: Источник не устанавливает влияние сдвига сна на эпидермальные иммунные клетки, повторную активацию NF-κB, вероятностные пороги между процедурами или заживление кожи. Исследование описывает сухожильно-костное соединение в модели восстановления ротаторной манжеты у крыс.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does timing treatment by skin-surface clocks worsen tissue mismatches, and can accounting for delays prevent unfinished repair?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Может ли выбор времени лечения по усиливать рассогласование с и после сдвига сна, и предотвращает ли учёт накопление незавершённого восстановления?

What this question is asking

The question concerns whether the daily timing of the skin’s outer layer is a reliable guide for scheduling treatment after sleep timing changes. It asks whether following that layer’s clock could put treatment ahead of the readiness of the deeper skin layer and , which participate in defense and repair. It then asks whether a schedule that accounts for timing differences between these tissues prevents unfinished repair from accumulating over weeks or months, compared with a schedule based only on the outer layer. This assumes that differences between reflect differences in readiness for treatment and that repeated treatment before all tissues are ready could leave repair unfinished; the supplied sources do not establish those links.

What the terms mean
Epidermis
The skin’s outer layer, called the skin surface or outer layer in this explanation. S4 estimates daily clock timing from a sample of this layer.
Dermis
The skin layer beneath the . The question asks whether its readiness for treatment can differ from the timing indicated by the outer layer.
Immune cells and immune signaling
participate in defense and tissue repair; immune signaling is the communication that regulates their activity. These terms cover many cell types and signals, rather than one uniform repair state.
Circadian clock, circadian phase, and clock oscillations
A circadian clock is a biological timing system with a cycle of roughly one day. Phase means the position within that cycle, while oscillations are the recurring rises and falls in measured activity. Knowing phase does not by itself establish readiness for treatment.
Tissue timing mismatches and delays
These describe differences in the timing of biological cycles across tissues. The question proposes that such differences could affect coordinated repair, but a clock difference is not automatically evidence of harmful disagreement.
ZeitZeiger and biomarkers
ZeitZeiger is the analysis method named in S4 for estimating daily clock timing from biological measurements. Biomarkers are measurable biological features used to indicate a condition or process; here, they indicate epidermal clock timing.
Treatment readiness and unfinished repair
Treatment readiness means the state in which a tissue could respond appropriately to the proposed treatment. Unfinished repair means repair activity or damage left unresolved between treatment periods. Neither has a specified measurement in the supplied material.
Fibroblasts, glioma cells, and neurons
are cells that help produce and maintain tissue structure; glioma cells are brain-tumor cells; neurons are nerve cells. S3 uses these different cell types as models for studying biological clocks, rather than measuring coordinated repair across intact skin.
Sleep restriction, sleep deprivation, and a sleep-timing shift
Sleep restriction reduces available sleep; sleep deprivation involves losing sleep; a sleep-timing shift changes when sleep occurs. These conditions can overlap, but findings about sleep loss do not automatically establish effects of changed sleep timing.
Skin barrier function
The skin’s ability to act as a protective boundary between the body and its surroundings. S6 reports damage to this function in mice.
Oxidative stress
A condition in which reactive chemicals overwhelm cellular protection and can damage cell components. S6 reports this form of skin damage after sleep restriction.
Nicotine
A biologically active substance examined alongside sleep deprivation in S9. Its presence is part of that study’s context, not an established explanation for the proposed tissue-clock mismatch.
Cell adhesion molecules and inflammation
Cell adhesion molecules help cells attach to other cells or surrounding structures. is a response to injury or threat that can participate in repair; measurements related to both were among the outcomes assessed in S8.
Gut–brain–skin connections
A collective name for interactions linking the digestive system, brain, and skin. S5 discusses disruption of these interactions, rather than directly comparing the clocks of different skin tissues.
What the question takes for granted
Premise only partly supported
Epidermal clock timing can be estimated, but after a sleep shift it may precede the readiness of the and ; repeated treatment based on epidermal timing may therefore accumulate unfinished repair.

The is the skin’s outer layer, the is the layer beneath it, and help defend and repair tissue. The assumption is that their daily clocks can indicate different times of readiness after a change in sleep timing, so treatment timed to the outer layer might arrive too early for the others. If this holds, accounting for those differences could provide a better guide to complete skin repair.

S4 establishes the narrower point that a set of measurements from one human epidermal sample can estimate its daily clock timing to within three hours. It does not establish that this estimate measures treatment readiness, that deeper tissues adjust more slowly after a sleep shift, or that timing treatment this way causes unfinished repair to accumulate. None of the supplied sources directly establishes those additional links. Their absence from this limited set does not show that the proposed mechanism is false.S4

The same question asked without the part nothing read establishes:

  • After a change in sleep timing, does treatment scheduled by the human epidermal clock increase timing differences with the and ?
  • After a change in sleep timing, does scheduling skin treatment using several tissues’ clock timings reduce unfinished repair compared with using epidermal timing alone?
What turns on the answer
  • Surface-based timing worsens mismatches; accounting for delays prevents unfinished repair Under the proposed mechanism, the outer layer indicates a treatment time before deeper tissues and are ready, and repeated mismatches leave repair unfinished. Accounting for their delays would then remove a scheduling-related cause of incomplete repair, making the outer-layer clock alone an insufficient guide.
  • Surface-based timing worsens mismatches; accounting for delays does not prevent unfinished repair Treatment timing would affect coordination between tissues, but correcting that coordination would not be sufficient to complete repair. A closer match between could therefore not be treated as evidence that unfinished repair had stopped accumulating.
  • Surface-based timing does not worsen mismatches The proposed first step, in which following the outer-layer clock increases disagreement between tissues, would not occur under the conditions assessed. Preventing that particular mismatch would then provide no demonstrated explanation for a benefit from a more complex schedule; overall effects on repair would remain a separate question.
Why it matters

A clock measurement could guide treatment only if the time it reports corresponds to a useful time for the processes that treatment affects. If different skin layers become ready at different times, following the outer layer alone could potentially schedule treatment before deeper repair processes are ready. Under the question’s proposed mechanism, repeating that mismatch could leave some repair unfinished, although the read sources do not demonstrate this sequence. Conversely, if these timing differences do not impair repair, treating them as harmful could make scheduling more complicated without an established benefit.

What is already established

Оценка и имеют ; не располагает проверенными правилами согласования всех слоёв.

What would have to be true

В течение недель и месяцев остаются допустимыми, остаточная активность не нарастает, коррекция режима практически выполнима.

What is missing

Неизвестно, улучшает ли привязка к восстановление органа при сдвиге сна или систематически опережает готовность других тканей.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

После сдвига сна эпидермально привязанное воздействие может попадать в период повышенной местных . Случайные колебания активности тогда чаще пересекают ядерного фактора . Каждый отдельный ответ завершается, однако новые краткие активации вновь поддерживают воспаление и . Накопление незавершённого восстановления определяется вероятностью таких событий между процедурами. Расписание, учитывающее только средние , может оказаться недостаточным: для устойчивости SPV_6 требуется ограничить вероятность повторного запуска воспаления.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

: модель с последующим . dx = −[x − m(t)]dt/τ + √(2D)dW_t; m(t) = m0 + a cos(φI(t)) + g u(t). Здесь t означает время; x представляет перед запуском ; m(t) является её текущим ; m0 задаёт базовый уровень; τ означает ; D задаёт интенсивность быстрых ; W_t является ; a представляет амплитуду ; φI(t) означает измеренную ; u(t) представляет измеренный локальный ; g переводит его в изменение активности . При достижении x = b регистрируется активация: b означает , затем x возвращается к уровню x_r и действует r. x_r и r измеряют восстановление . Проверяемая величина P(T_b < Δ) представляет вероятность за межпроцедурный интервал Δ; T_b является временем этого достижения. Это приближение кратковременной , не предполагающее второго . Параметры оценивают по одиночным воздействиям, затем проверяют на независимых последовательностях повторных воздействий.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых измеренных , состоянии и изменение слабого должно менять число отдельных повторных активаций и . В режиме, где средний вход ниже , увеличение должно повышать вероятность активации. Расписание, выбранное по индивидуально оценённой вероятности повторного запуска, должно превосходить расписание по среднему при одинаковых числе процедур, суммарном воздействии и сроке наблюдения. Гипотеза опровергается, если не влияет на повторные активации в установленном либо если их изменение не влияет на завершение восстановления.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies a directional change in activation probability, a schedule comparison under matched conditions, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Первую проверку можно провести в , и с и . Сначала необходимо подтвердить наличие и измерить одних и тех же клеток. Стабильные различия чувствительности между клетками следует отделить от случайности повторных ответов.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых измеренных , состоянии и изменение слабого должно менять число отдельных повторных активаций и . В режиме, где средний вход ниже , увеличение должно повышать вероятность активации. Расписание, выбранное по индивидуально оценённой вероятности повторного запуска, должно превосходить расписание по среднему при одинаковых числе процедур, суммарном воздействии и сроке наблюдения. Гипотеза опровергается, если не влияет на повторные активации в установленном либо если их изменение не влияет на завершение восстановления.

  • What would separate them

    Synchronized cilium loss may prolong skin growth by removing a brake on cell-cycle re-entry predicts: В сравнить узкое и широкое при одинаковых средней фазе, индивидуальной , составе клеток, повреждении и суммарном лечении. Проверять фактические и дополнительно воспроизводить их в . Гипотеза предсказывает, что более широкое уменьшит длительность общей утраты и перед следующим циклом. Восстановление после начальной должно устранить преимущество , сохраняя исходное рассогласование . Гипотеза опровергается, если изменение при подтверждённой не меняет завершение роста, а исход определяется частотой повторных воспалительных импульсов.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.